- Home
- RWT vs VIR Comparison
RWT vs VIR Comparison
Compare RWT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- VIR
- Stock Information
- Founded
- RWT 1994
- VIR 2016
- Country
- RWT United States
- VIR United States
- Employees
- RWT N/A
- VIR N/A
- Industry
- RWT Real Estate Investment Trusts
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- VIR Health Care
- Exchange
- RWT Nasdaq
- VIR Nasdaq
- Market Cap
- RWT 756.1M
- VIR 844.9M
- IPO Year
- RWT 1995
- VIR 2019
- Fundamental
- Price
- RWT $5.90
- VIR $5.13
- Analyst Decision
- RWT Buy
- VIR Strong Buy
- Analyst Count
- RWT 11
- VIR 7
- Target Price
- RWT $7.59
- VIR $32.86
- AVG Volume (30 Days)
- RWT 990.4K
- VIR 1.1M
- Earning Date
- RWT 07-31-2025
- VIR 07-31-2025
- Dividend Yield
- RWT 12.16%
- VIR N/A
- EPS Growth
- RWT 105.35
- VIR N/A
- EPS
- RWT 0.21
- VIR N/A
- Revenue
- RWT $241,796,000.00
- VIR $20,861,000.00
- Revenue This Year
- RWT N/A
- VIR N/A
- Revenue Next Year
- RWT $3.43
- VIR N/A
- P/E Ratio
- RWT $28.07
- VIR N/A
- Revenue Growth
- RWT 29.65
- VIR N/A
- 52 Week Low
- RWT $4.68
- VIR $4.32
- 52 Week High
- RWT $8.15
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- RWT 54.19
- VIR 48.62
- Support Level
- RWT $5.40
- VIR $5.00
- Resistance Level
- RWT $5.83
- VIR $5.35
- Average True Range (ATR)
- RWT 0.14
- VIR 0.24
- MACD
- RWT 0.02
- VIR 0.02
- Stochastic Oscillator
- RWT 69.61
- VIR 31.21
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.